Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that the first patient has been successfully dosed in the Phase III ...
GOTHENBURG, SWEDEN / ACCESS Newswire / February 27, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a compa ...
HYDERABAD: Even with the advantage of a high population, experts said India has failed to leverage its advantage to become a ...
Regarding patients with HER2-negative, estrogen receptor (ER)-positive breast cancer, the phase 3 KEYNOTE-756 study is ...
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to 4-fold increase in neutralizing ...
Experts discuss the crucial role of government in enhancing India's participation in clinical trials at BioAsia 2025 panel.
The partnership focuses on radioligand therapy, cell therapy, and early-phase trials. Singapore General Hospital (SGH) and ...
London researchers launched a study in 2019 to see if the beneficial poop microbes could improve the effectiveness of ...
Initiated the Phase 3 VELA program of the Nanobody ® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa ...
Glenda Gray, program director of a research consortium, talked with STAT about the impact of the funding freeze on an HIV ...
Spanish biopharmaceutical company Biofabri and nonprofit scientific research organization IAVI announced today that the first ...
Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET. Company Participants. Katie Hogan - Senior Director-Corporate Communications and Investo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback